Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
167.50
-15.50 (-8.47%)
At close: Dec 5, 2025

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
259,77594,36523,5407,528--
Upgrade
Market Cap Growth
231.32%300.87%212.69%---
Upgrade
Enterprise Value
253,26484,68522,6946,297--
Upgrade
Last Close Price
167.5061.5019.136.11--
Upgrade
PS Ratio
7424.282123.71604.64587.23--
Upgrade
PB Ratio
27.709.736.296.47--
Upgrade
P/TBV Ratio
27.709.736.296.47--
Upgrade
EV/Sales Ratio
-1905.86582.91491.18--
Upgrade
Debt / Equity Ratio
0.000.000.010.030.062.81
Upgrade
Asset Turnover
0.000.010.020.010.030.05
Upgrade
Inventory Turnover
2.657.045.992.252.412.89
Upgrade
Quick Ratio
112.80183.4250.4823.0415.001.45
Upgrade
Current Ratio
114.40184.0250.8123.4115.261.72
Upgrade
Return on Equity (ROE)
-5.11%-8.76%-19.92%-31.64%-64.89%-528.22%
Upgrade
Return on Assets (ROA)
-4.64%-6.59%-12.68%-20.53%-30.68%-33.22%
Upgrade
Return on Capital (ROIC)
-4.67%-6.65%-12.96%-21.32%-33.58%-40.80%
Upgrade
Return on Capital Employed (ROCE)
-7.60%-7.40%-13.70%-27.00%-34.30%-64.90%
Upgrade
Earnings Yield
-0.19%-0.62%-2.08%-3.80%--
Upgrade
FCF Yield
-0.16%-0.56%-1.84%-3.41%--
Upgrade
Buyback Yield / Dilution
-13.14%-15.40%-5.77%-27.35%-23.49%-6.52%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.